Unison Pharmaceuticals Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimison-VM 1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimison-VM 1 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimison-VM 1 Tablet SR.
Glimison-VM 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimison-VM 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimison-VM 1 Tablet SR is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimison-VM 1 Tablet SR is a medication used to treat type 2 diabetes mellitus in adults. It combines three active ingredients: glimepiride, metformin, and voglibose.
Common side effects of Glimison-VM 1 Tablet SR may include low blood sugar levels (hypoglycemia), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infections.
Glimison-VM 1 Tablet SR is contraindicated in patients with known allergies to its components or excipients. It should also be avoided in individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
No, consuming alcohol while taking Glimison-VM 1 Tablet SR can increase the risk of low blood sugar levels (hypoglycemia) and lactic acidosis.
Yes, Glimison-VM 1 Tablet SR may cause low blood sugar levels (hypoglycemia), which can be triggered by skipping or delaying meals, excessive exercise, consuming alcohol, or taking other antidiabetic medications. Regular monitoring of blood glucose levels is essential.
Store Glimison-VM 1 Tablet SR in its original packaging, tightly closed. Dispose of any unused medicine according to the manufacturer's guidelines, ensuring it does not come into contact with pets, children, or other individuals.